Literature DB >> 2999322

High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity.

G Frisk, J Fohlman, M Kobbah, U Ewald, T Tuvemo, H Diderholm, G Friman.   

Abstract

Twenty-four consecutive children with newly diagnosed insulin-dependent (type I) diabetes mellitus (IDDM) were investigated for a history of infectious disease. Thirteen of the 24 (54%) patients reported symptoms of acute infection within two months before diabetes was diagnosed. The mean age was 8.5 years and 15 (63%) of the patients were girls. No clear seasonal variation in onset was seen. Coxsackie B (CB)-virus-specific IgM responses were detected by reverse radioimmunoassay (RIA) in 16 of the 24 (67%) patients on the day of diagnosis of IDDM. The highest titre was usually recorded at that time, but with some the highest titre was found with a second serum obtained three to seven weeks after diagnosis. Thereafter the titres declined, and after six months IgM was detected only in a few patients. Thirteen patients displayed monotypic IgM responses, whereas three patients showed ditypic responses. Among the former, IgM was recorded against Coxsackie B4 (CB4) in four, B5 (CB5) in three, B1 (CB1) in two, B2 (CB2) in two, and B3 (CB3) in two patients. The ditypic responses were against CB2 and CB3, CB3 and CB4, and CB5. No CB-virus-specific IgM was detected in sera, found during the same period, from age-matched nondiabetic children without evidence of infection. In neutralisation (NT) tests, antibodies to the homotypic virus were found in 12 of the 16 diabetic patients showing CB-virus-specific at the time of diagnosis. A significant rise in NT titre was demonstrated in three of these patients. No significant clinical difference was noted between IgM positive and IgM negative patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999322     DOI: 10.1002/jmv.1890170303

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

Review 1.  Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.

Authors:  Mikael Knip
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

3.  Subclass restriction of human enterovirus antibodies.

Authors:  E G Torfason; C B Reimer; H L Keyserling
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

Review 4.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 5.  Saffold virus, a novel human Cardiovirus with unknown pathogenicity.

Authors:  Toshiki Himeda; Yoshiro Ohara
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

6.  Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.

Authors:  Oskar Skog; Sofie Ingvast; Olle Korsgren
Journal:  J Clin Virol       Date:  2014-07-30       Impact factor: 3.168

7.  Comparative evaluation of immunoglobulin M neutralizing antibody response in acute-phase sera and virus isolation for the routine diagnosis of enterovirus infection.

Authors:  B Pozzetto; O G Gaudin; M Aouni; A Ros
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

8.  Coxsackievirus B3-induced acute pancreatitis: analysis of histopathological and viral parameters in a mouse model.

Authors:  T Vuorinen; M Kallajoki; T Hyypiä; R Vainionpää
Journal:  Br J Exp Pathol       Date:  1989-08

Review 9.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

10.  Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM.

Authors:  G Dahlquist; G Frisk; S A Ivarsson; L Svanberg; M Forsgren; H Diderholm
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.